Flow Traders U.S.’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,556
Closed -$1.32M 1198
2025
Q4
$1.32M Buy
+9,556
New +$1.25M 0.04% 309
2025
Q1
Sell
-2,394
Closed -$233K 1193
2024
Q4
$233K Buy
+2,394
New +$255K 0.01% 845
2024
Q3
Sell
-13,726
Closed -$1.46M 1078
2024
Q2
$1.46M Buy
+13,726
New +$1.38M 0.07% 263
2021
Q1
Sell
-7,497
Closed -$708K 929
2020
Q4
$708K Buy
+7,497
New +$655K 0.05% 322
2019
Q3
Sell
-2,392
Closed -$218K 378
2019
Q2
$218K Sell
2,392
-2,493
-51% -$211K 0.01% 258
2019
Q1
$421K Buy
+4,885
New +$392K 0.02% 226
2018
Q3
Sell
-4,853
Closed -$329K 293
2018
Q2
$329K Buy
+4,853
New +$335K 0.03% 169
2017
Q1
Sell
-3,560
Closed -$232K 440
2016
Q4
$232K Buy
3,560
+1,250
+54% +$81.1K 0.01% 272
2016
Q3
$163K Buy
+2,310
New +$168K 0.02% 227
2016
Q2
Sell
-982
Closed -$64K 313
2016
Q1
$64K Buy
+982
New +$66.8K 0.01% 189
2015
Q3
Sell
-1,666
Closed -$147K 206
2015
Q2
$147K Sell
1,666
-876
-34% -$80.4K 0.03% 110
2015
Q1
$225K Buy
+2,542
New +$225K 0.05% 94
2014
Q4
Sell
-8,290
Closed -$699K 214
2014
Q3
$699K Buy
+8,290
New +$671K 0.09% 75
2013
Q4
Sell
-66,545
Closed -$4.57M 261
2013
Q3
$4.57M Buy
+66,545
New +$4.4M 0.72% 33

Other funds holding NVS

Flow Traders U.S.'s NVS Position: Q1 2026 in Review

Flow Traders U.S. sold out of Novartis (NVS) in Q1 2026, closing a stake of 9,556 shares — an estimated $1.32M sold.

Flow Traders U.S. first reported a position in NVS in Q3 2013 and held it in 14 quarters. The position peaked at $4.57M in Q3 2013. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Flow Traders U.S. reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Flow Traders U.S. sold 9,556 Novartis shares in Q1 2026, an estimated $1.32M.
  • Flow Traders U.S. first reported a position in Novartis in Q3 2013 and held it in 14 quarters.
  • Flow Traders U.S.'s Novartis position peaked at $4.57M in Q3 2013.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.